Understanding Peptide Half-Life in Research Protocols

What Is Half-Life?

Half-life is how long it takes for a compound to drop to 50% in your bloodstream. After one half-life, 50% is left. After two, 25%. After five half-lives, 97% is gone.

For peptides, the main reason for short half-lives is proteases-enzymes that chop up peptides. That's why researchers often modify peptides to make them last longer.

Why Half-Life Matters for Dosing Frequency

Half-life determines how often you need to dose. Short half-life = multiple doses per day. Long half-life = once a week.

For GH research, this matters even more. Real GH pulses-it doesn't stay high constantly. So GH-related peptides often keep short half-lives to mimic that natural pulse. But some researchers want sustained levels instead, so they engineer long half-lives for those studies.

Half-Life Examples Across Research Peptides

BPC-157: ~4 hours. Twice daily in animal studies.

CJC-1295 without DAC: ~20-30 minutes. Mirrors natural GHRH pulses. Often paired with Ipamorelin to boost GH pulses while keeping them pulsatile.

CJC-1295 with DAC: ~6-8 days. The DAC linker glues it to albumin (blood protein), so it lasts way longer. Produces steady GH elevation instead of pulses.

Ipamorelin: ~2 hours. Selective for GH-doesn't mess with cortisol or prolactin.

Semaglutide: ~7 days. Albumin binding + fatty acid modification = once weekly dosing.

Pulsatile vs. Sustained Release

Pulsatile GH (like nature) affects fat and muscle differently than constant high GH. So half-life isn't just about convenience-it changes the biology. Researchers have to account for this when comparing compounds.

Half-Life Calculators

Use calculators to model how blood levels change over time. They help estimate how long to reach steady-state (about 4-5 half-lives), when to redose, and overlapping concentrations. They're rough guides, not perfect-individual differences and route of administration affect real outcomes.

--- For research use only. Not medical advice.